tiprankstipranks
Atara Biotherapeutics (ATRA)
NASDAQ:ATRA

Atara Biotherapeutics (ATRA) Stock Investors

1,043 Followers
Based on 729,232 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold ATRA
On average, investors allocate 2.61% of their portfolios to ATRA
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding ATRA

1.4%
Last 7
Days
7.5%
Last 30
Days
Percentages indicate the change in the number of portfolios holding ATRA, out of 729,232 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

ATRA Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.15%
$0.65
Increased
1.56%
$1.32
Increased
2.68%
$0.80
Based on the activity of 13,701 investors who made their portfolios public
The table shows changes in ATRA in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

ATRA Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Merck & Company
4.14%
-0.42%
-1.47%
318.56B
Healthcare
Block
4.47%
-1.21%
-7.51%
43.36B
Technology
Coherus Biosciences
2.64%
-1.40%
-8.48%
234.94M
Healthcare
Micron
5.67%
+0.11%
+12.41%
118.23B
Technology
GE Aerospace
5.50%
+1.58%
+6.13%
161.87B
Industrials
Salesforce
4.97%
+1.16%
-0.46%
262.26B
Technology
ChargePoint Holdings
3.89%
-1.27%
-7.40%
575.77M
Consumer Cyclical
Riot Platforms
4.96%
-0.82%
-0.97%
2.31B
Financial
Plug Power
4.91%
-1.07%
-6.60%
1.76B
Industrials
AbbVie
5.75%
-0.36%
-3.44%
294.65B
Healthcare
Based on the activity of 729,232 active portfolios
Open your Smart Portfolio

ATRA Investor Analysis

ATRA investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
15.9%
of ATRA holders
are under 35
Average Segment Performance
Average P/E Ratio55.48
Beta6.58
Dividend Yield6.31%
ATRA investors between 35–55

Between 35–55

6.3%
Last 30 days
Holdings Change
57.9%
of ATRA holders
are between 35–55
Average Segment Performance
Average P/E Ratio59.75
Beta11.38
Dividend Yield17.85%
ATRA investors over 55

Over 55

4.8%
Last 30 days
Holdings Change
26.2%
of ATRA holders
are over 55
Average Segment Performance
Average P/E Ratio50.99
Beta4.10
Dividend Yield29.58%
Overview of age group and performance of ATRA stock investors
See who invests in ATRA according to age group and performance.

FAQ

How many retail Investors hold ATRA?
<0.1% of TipRanks' retail investors hold ATRA in their portfolios.
    What is ATRA Investor Sentiment?
    ATRA’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of ATRA in the last 7 days?
      ▼ 1.4% of TipRanks' retail investors changed their holding of ATRA in the last 7 days.
        What percentage of retail investors changed their holding of ATRA in the last 30 days?
        ▼ 7.5% of TipRanks' retail investors changed their holding of ATRA in the last 30 days.
          What is the average age of retail investors who hold ATRA?
          The average age of ATRA Holders is between 35–55.
            What other stocks have ATRA investors also bought?
            ATRA Investors also bought MRK, SQ, CHRS, MU, GE, CRM, CHPT, RIOT, PLUG, ABBV.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              AAgilent
              CORCencora
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis